NVIDIA's investment in Safe Superintelligence will 10x the lab's compute in 12 months, cementing its toll-booth position in the AI buildout.
NVIDIA's investment in Safe Superintelligence will 10x the lab's compute in 12 months, cementing its toll-booth position in the AI buildout.

NVIDIA's investment in Safe Superintelligence, Ilya Sutskever's secretive AI lab, will 10x the startup's compute capacity within 12 months, deepening the chipmaker's grip on the frontier AI infrastructure cycle. The announcement, made after The Wall Street Journal reported NVIDIA received a "rare glimpse" into SSI's research, pushed shares up 1.74 percent to $210.23 after closing at $206.64 on August 3. The stock has advanced 17.5 percent over the past year and 943.9 percent over five years.
"SSI will 10x our compute in the next 12 months," the joint announcement said, describing the investment as "substantial" and part of a long-term strategic partnership. Superintelligence, in this context, refers to AI systems that exceed human capability across essentially all cognitive tasks — the stated goal of the lab Sutskever founded after leaving OpenAI.
The investment adds another named frontier customer to NVIDIA's roster alongside OpenAI, Anthropic, Meta, and Google Cloud. Every dollar SSI spends chasing superintelligence ultimately routes through NVIDIA silicon fabricated by Taiwan Semiconductor Manufacturing, whose Q2 2026 revenue grew 36 percent year over year on the same wave. NVIDIA's Q1 FY2027 revenue reached $81.615 billion, up 85.23 percent year over year, with non-GAAP EPS of $1.87 and free cash flow of $48.554 billion in a single quarter. Management guides Q2 FY27 revenue to $91.0 billion at a 75.0 percent non-GAAP gross margin, with total supply commitments swelling to $119.0 billion from $50.3 billion two quarters earlier.
At $210.23, NVIDIA trades at 22.8 times forward earnings against 85 percent revenue growth — a multiple below the S&P 500's typical growth-stock band. Analyst consensus price target stands at $302.83, backed by 48 Buy ratings and 10 Strong Buys against just 2 Holds and 1 Sell.
The deal echoes the vendor-financing patterns of the 2000-era telecom bubble, when equipment makers lent money to customers who then bought more equipment. NVIDIA's $30.0 billion in multi-year cloud service commitments and its $119 billion supply book create real execution risk if hyperscaler capex softens. Forward guidance excludes any Data Center compute revenue from China, and insider direction across 26 recent transactions is net selling. Polymarket traders assign only a 51.5 percent probability that NVDA closes August above $210, and just a 21.5 percent shot above $230.
Yet the comparison to 2000 breaks down on one critical dimension: NVIDIA doesn't have to push hardware on anyone. Blackwell 300 is ramping, Vera Rubin is announced, and the company's $80 billion buyback authorization shows management's confidence in the cash-generation machine. The SSI investment, like the earlier $5 billion bet on Thinking Machines Lab, is a bet that frontier labs will keep scaling compute — and that NVIDIA will keep collecting the toll.
The setup remains constructive for growth-oriented investors. A forward multiple of roughly 23 on a business growing revenue 85 percent year over year, with 75 percent gross margins and $48.5 billion in quarterly free cash flow, is a price a long-term investor can defensibly pay for the dominant supplier to the AI infrastructure cycle. The SSI investment adds one more data point to the same thesis: frontier labs will keep scaling compute, and NVIDIA sits at the toll booth.
The risks are real but identifiable: hyperscaler capex digestion, China revenue exclusion, and the circularity of NVIDIA's deal-making. The 200-day moving average near $193 is the level to watch for investors weighing a new entry against the announcement-driven pop. NVIDIA is not cheap in absolute terms, but the multiple still looks reasonable if the AI infrastructure cycle keeps converting into revenue, margin, and cash.
This article is for informational purposes only and does not constitute investment advice.